Insider Transactions of Carl Dambkowski at Apogee Therapeutics, Inc.

Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc., executed several transactions on July 1, 2026. He acquired 4,125 shares of Common Stock at a price of $22.86 per share, increasing his post-transaction holdings to 183,373 shares. Concurrently, he disposed of 5,500 shares of Common Stock at $132.74 per share, resulting in 177,873 shares remaining. Additionally, Mr. Dambkowski exercised a stock option to acquire 4,125 shares of Common Stock at a price of $0.00, with an exercise price of $22.86 per share, leaving him with 114,790 shares post-transaction. Some of these transactions were made under a Rule 10b5-1 trading plan.